Canada Approves Novavax Vaccine For Canadian Adults
#Novavax #CovidVaccine #novavax #vaccines #vaccinework #Canada
Health Canada has approved the Novavax COVID-19 vaccine, adding a fifth option to Canada’s arsenal that may see more uptick from people who remain hesitant to get a dose.
The vaccine, called Nuvaxovid, is 90 per cent effective at preventing symptomatic infection and 100 per cent effective at preventing severe disease based on clinical trials, Health Canada said in a statement Thursday.
The regulator also said that “preliminary and exploratory data shows” that the vaccine “does produce neutralizing antibodies against the Omicron variant,” but that additional data is needed to confirm that.
“As a term and condition associated with the authorization, Novavax is required to provide data regarding protection against current and emerging variants of concern as soon as it is available,” Health Canada said.
The Novavax shots have already been cleared for use in Europe, Australia and Singapore.
Canada has committed to purchase 52 million doses of the vaccine, with an option to buy up to 24 million doses more.
Novavax’s recombinant protein vaccine, Nuxavoxid, uses a more established technology than mRNA, the novel method behind the two most commonly used COVID-19 vaccines – from Pfizer (PFE.N)/BioNTech and Moderna (MRNA.O).